About Us

Exploring Antibodies, Creating Novel Biologics

Greeting from CEO

Young Woo Park

Y-Biologics is a biotechnology company focused on the discovery of antibody therapeutics with proprietary platform technologies. We have secured own fully human antibody library,
Ymax®-ABL (See more) , with phage display technology and have generated several antibody pipelines in various modalities. Furthermore, we have developed novel T cell bispecific antibody platform technology, ALiCE (Antibody Like Cell Engager) which has potential to address current unmet needs in fields of immuno-oncology.

Based on our experiences and expertise, we would like to provide antibody discovery services globally. We shall continue our innovation not only to develop antibody therapeutics but also will contribute to the global biotech industry as a leading biopharmaceutical company in the fields of immuno-oncology.

As a reliable service provider, Y-Biologics will guide your journey for generating antibodies with high quality. We keep trying to pursue the best results by fully utilizing our techniques and resources to complete the client’s projects. Besides, we offer bespoke services based on the purpose of research and specific requests of the clients.

To learn more about Y-Biologics, visit our company website:

START UP

Constructed fully human antibody library platform

Verification

Strengthen competitiveness in antibody discovery targeted
for immuno-oncology therapeutics

Leap Forward

Building up T cell bispecific antibody based on ALiCE^TM technology

Sustainable Growth

Business expansion through listing

START UP

Constructed fully human antibody library platform

Verification

Strengthen competitiveness in antibody discovery targeted
for immuno-oncology therapeutics

Leap Forward

Building up T cell bispecific antibody based on ALiCE^TM technology

Sustainable Growth

Business expansion through listing

Start up

Growing

Developing

Thriving